Telmisartan-13C,d3 structure
|
Common Name | Telmisartan-13C,d3 | ||
---|---|---|---|---|
CAS Number | 1261396-33-1 | Molecular Weight | 518.63 | |
Density | 1.2±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C3213CH27D3N4O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Telmisartan-13C,d3Telmisartan-13C,d3 is the 13C- and deuterium labeled. Telmisartan is a potent, long lasting antagonist of angiotensin II type 1 receptor (AT1), selectively inhibiting the binding of 125I-AngII to AT1 receptors with IC50 of 9.2 nM. |
Name | 4'-{[7'-Methyl-1-(13C,2H3)methyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl]methyl}-2-biphenylcarboxylic acid |
---|---|
Synonym | More Synonyms |
Description | Telmisartan-13C,d3 is the 13C- and deuterium labeled. Telmisartan is a potent, long lasting antagonist of angiotensin II type 1 receptor (AT1), selectively inhibiting the binding of 125I-AngII to AT1 receptors with IC50 of 9.2 nM. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[55]. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Molecular Formula | C3213CH27D3N4O2 |
Molecular Weight | 518.63 |
Exact Mass | 518.259033 |
Index of Refraction | 1.667 |
[1,1'-Biphenyl]-2-carboxylic acid, 4'-[[4'-methyl-1-(methyl-13C-d3)-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl]methyl]- |
4'-{[7'-Methyl-1-(13C,2H3)methyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl]methyl}-2-biphenylcarboxylic acid |